Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AMEPAROMO CAPSULES 250 MG DRUG USE INVESTIGATION

NCT02680665 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT02680665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02680665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AMEPAROMO CAPSULES 250 MG DRUG USE INVESTIGATION
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
October 19, 2015
Completion date
December 21, 2018
Enrollment
120 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intestinal amebiasis